A detailed history of Annapolis Financial Services, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Annapolis Financial Services, LLC holds 789 shares of PFE stock, worth $23,401. This represents 0.01% of its overall portfolio holdings.

Number of Shares
789
Previous 1,289 38.79%
Holding current value
$23,401
Previous $35,000 37.14%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$25.26 - $29.6 $12,630 - $14,800
-500 Reduced 38.79%
789 $22,000
Q1 2024

Apr 17, 2024

SELL
$25.89 - $29.73 $2,589 - $2,973
-100 Reduced 7.2%
1,289 $35,000
Q4 2023

Jan 31, 2024

SELL
$26.13 - $33.94 $6,741 - $8,756
-258 Reduced 15.66%
1,389 $39,000
Q3 2023

Oct 30, 2023

SELL
$32.09 - $37.51 $57,088 - $66,730
-1,779 Reduced 51.93%
1,647 $54,000
Q2 2023

Jul 18, 2023

BUY
$36.12 - $41.79 $1,336 - $1,546
37 Added 1.09%
3,426 $125,000
Q1 2023

Apr 17, 2023

SELL
$39.39 - $51.28 $39 - $51
-1 Reduced 0.03%
3,389 $138,000
Q4 2022

Jan 20, 2023

SELL
$41.75 - $54.5 $31,771 - $41,474
-761 Reduced 18.33%
3,390 $0
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $32,426 - $39,584
741 Added 21.73%
4,151 $182,000
Q2 2022

Jul 22, 2022

BUY
$46.53 - $55.17 $5,862 - $6,951
126 Added 3.84%
3,410 $179,000
Q1 2022

Apr 29, 2022

SELL
$45.75 - $56.69 $2,973 - $3,684
-65 Reduced 1.94%
3,284 $170,000
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $6,239 - $9,248
-151 Reduced 4.31%
3,349 $198,000
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $7,732 - $9,932
197 Added 5.96%
3,500 $151,000
Q2 2021

Aug 04, 2021

BUY
$35.91 - $40.68 $7,397 - $8,380
206 Added 6.65%
3,303 $129,000
Q1 2021

May 06, 2021

BUY
$33.49 - $37.77 $67,314 - $75,917
2,010 Added 184.91%
3,097 $112,000
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $36,381 - $46,262
1,087 New
1,087 $40,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Annapolis Financial Services, LLC Portfolio

Follow Annapolis Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annapolis Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annapolis Financial Services, LLC with notifications on news.